Critical Care

official impact factor 4.60

Download references

Open Access Highly Access

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study

Mirjam K Rommers*, Netty Van Der Lely, Toine CG Egberts and Patricia MLA van den Bemt

Critical Care 2006, 10:R93 doi:10.1186/cc4952

Include


Format